BETA: Please send your feedback!
Zhejiang RIFA Precision Machinery
002520-CN:SHE
Industrial Machinery
—
SMALL cap
(—)
—
since start of 2019
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Major
Founded 2002
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its products include cardiovascular, rare diseases, immune-oncology, and ophthalmology. The company was founded by J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.
website
Headquarters
Executives
| Name | Title | Gender |
| Ben Shan Wang | Chairman & President | Male |
| Xin Xia | Chairman-Supervisory Board | Male |
| Guo Xiang Zhou | Director-Finance | Male |
| Chong Wen Pei | Chief Engineer | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Reata Pharmaceuticals - Competitors and Related Companies
How Reata Pharmaceuticals stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
Reata Pharmaceuticals
RETA:NAS
Pharmaceuticals: Major
$1.74bn
SMALL cap
$71.26
(-3.34%)
0.23%
since start of 2019
-17.57
Loading…